Compare VTAK & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTAK | ALBT |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 4.0M |
| IPO Year | 2018 | 2015 |
| Metric | VTAK | ALBT |
|---|---|---|
| Price | $0.45 | $0.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 11.4M | 579.8K |
| Earning Date | 08-11-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.53 | 33.18 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $442,000.00 | N/A |
| Revenue This Year | $1,170.33 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3057.14 | N/A |
| 52 Week Low | $0.15 | $0.21 |
| 52 Week High | $4.31 | $4.74 |
| Indicator | VTAK | ALBT |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 49.28 |
| Support Level | N/A | $0.28 |
| Resistance Level | $1.22 | $0.39 |
| Average True Range (ATR) | 0.17 | 0.03 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 9.48 | 73.98 |
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
Avalon Globocare Corp is a technology driven company with a focus on developing products and services that serve growing consumer health and technology markets. Through its AI-driven subsidiary, the company is advancing next-generation AI systems, including automated video generation, enterprise documentation, and workflow automation solutions. Its segments consist of a consumer health technology segment, through which it distributes the Keto Air breathalyzer device, a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America; and an artificial intelligence content technology segment, through which it develops and commercializes an AI-driven, short-form video generation platform.